Zeiher Bernhardt G 4

What Happened

• Bernhardt G. Zeiher, a director of Abeona Therapeutics, was granted 37,313 restricted shares on January 26, 2026. The Form 4 reports an acquisition price of $0.00 (total reported value $0), indicating these were company-awarded restricted shares rather than a market purchase.

Key Details

• Transaction date: 2026-01-26; transaction type/code: Award/Grant (A)
• Shares granted: 37,313 at $0.00 per share (total reported $0)
• Vesting: All restricted shares vest on January 26, 2027 (footnote)
• Shares owned after transaction: not specified in the excerpt of the filing
• Filing/timeliness: Form filed 2026-01-27 (appears timely; no late filing noted)
• No 10b5-1 plan, sale, or exercise activity reported in this transaction

Context

• This was a restricted stock grant to a board member. Such awards are typically part of director compensation and vest over time; they do not represent an open-market purchase or sale. Grants can align a director’s interests with shareholders but do not by themselves indicate near-term buying or selling intent.